Panel formed to administer pricing reforms for drugs, medical devices

Centre constitutes Committee for reforms in pricing framework for drugs and medical devices

Soon, pricing regulations for drugs and medical devices in India may undergo reforms as the Centre appoints a committee to propose changes to the pricing framework.

Industry sources suggest that a new Drug (Prices Control) Order (DPCO) may be in the works, considering the current DPCO 2013 is already 11 years old.

Pricing regulations are periodically reviewed to ensure relevance for both the industry and consumers, informed a source.

In a March notification, the Department of Pharmaceuticals (DoP) said that a committee is constituted for “reforms in the pricing framework for drugs and medical devices” with the approval of a